Aspire Health Partners, Inc.

Audits
3
Findings
14
Total Expended
$89.14M
Latest Accepted
2025-03-28
Location: Orlando, FL
UEI: HNB4DEYQ3373 EIN: 592301233

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Linda Damm CFO Auditee
Erik A. Halluska, Cpa Shareholder Auditee
Parissa Sadri VP OF ACCOUNTING Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
350215 2024 2025-03-28 Withumsmith+brown PC $28.16M
302073 2023 2024-04-01 Withumsmith+brown PC $30.38M
40712 2022 2023-01-05 Withumsmith+brown PC $30.60M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
302073 2023 2024-04-01 968066 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 968065 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 968064 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 968063 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 968062 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 968061 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 968060 2023-002 Significant Deficiency - L
302073 2023 2024-04-01 391624 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 391623 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 391622 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 391621 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 391620 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 391619 2023-001 Significant Deficiency - L
302073 2023 2024-04-01 391618 2023-002 Significant Deficiency - L